Sarita Kapila
Stock Analyst at Morgan Stanley
(0.53)
# 4,246
Out of 4,649 analysts
59
Total ratings
38.2%
Success rate
-7%
Average return
Main Sectors:
Stocks Rated by Sarita Kapila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: SAN Sanofi | Maintained: Hold | €100.00 → €82.00 | €75.52 | +8.58% | 2 | Aug 11, 2026 | |
| RHHBY Roche Holding AG | Upgraded: Buy | $46 → $504 | $54.52 | +824.41% | 3 | Aug 7, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,500p → 15,300p | 11,460p | +33.51% | 12 | Jul 16, 2026 | |
| SNY Sanofi | Maintained: Hold | $52 → $49 | $43.72 | +12.08% | 4 | Jul 8, 2026 | |
| SWX: ROP Roche Holding AG | Upgraded: Hold | CHF 295.00 | CHF 355.10 | -16.92% | 10 | Apr 24, 2026 | |
| LON: 0NZT UCB SA | Downgraded: Hold | €260.00 | €215.55 | +20.62% | 6 | Mar 6, 2026 | |
| LON: GSK GSK plc | Maintained: Sell | 1,600p → 1,700p | 1,818p | -6.46% | 8 | Mar 2, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Maintained: Hold | kr 253.10 → kr 257.88 | kr 440.40 | n/a | 2 | May 4, 2023 | |
| GRFS Grifols | Maintained: Buy | $16 → $19 | $7.78 | n/a | 2 | Feb 8, 2023 | |
| BME: GRF Grifols, S.A. | Maintained: Buy | €14.00 → €16.00 | €9.86 | n/a | 6 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $36 | $52.68 | n/a | 4 | Nov 16, 2022 |
Sanofi
Aug 11, 2026
Maintained: Hold
Price Target: €100.00 → €82.00
Current: €75.52
Upside: +8.58%
Roche Holding AG
Aug 7, 2026
Upgraded: Buy
Price Target: $46 → $504
Current: $54.52
Upside: +824.41%
AstraZeneca PLC
Jul 16, 2026
Maintained: Buy
Price Target: 16,500p → 15,300p
Current: 11,460p
Upside: +33.51%
Sanofi
Jul 8, 2026
Maintained: Hold
Price Target: $52 → $49
Current: $43.72
Upside: +12.08%
Roche Holding AG
Apr 24, 2026
Upgraded: Hold
Price Target: CHF 295.00
Current: CHF 355.10
Upside: -16.92%
UCB SA
Mar 6, 2026
Downgraded: Hold
Price Target: €260.00
Current: €215.55
Upside: +20.62%
GSK plc
Mar 2, 2026
Maintained: Sell
Price Target: 1,600p → 1,700p
Current: 1,818p
Upside: -6.46%
Swedish Orphan Biovitrum AB (publ)
May 4, 2023
Maintained: Hold
Price Target: kr 253.10 → kr 257.88
Current: kr 440.40
Upside: n/a
Grifols
Feb 8, 2023
Maintained: Buy
Price Target: $16 → $19
Current: $7.78
Upside: n/a
Grifols, S.A.
Feb 8, 2023
Maintained: Buy
Price Target: €14.00 → €16.00
Current: €9.86
Upside: n/a
Nov 16, 2022
Downgraded: Hold
Price Target: $36
Current: $52.68
Upside: n/a